KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
发明人:
CHUNG, BONG HYUN,YI, SO YOEN,LEE, UI JIN
申请号：
CA2845496
公开号：
CA2845496A1
申请日:
2012.06.28
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
The present invention relates to a novel compound isolated from quamoclit, and to a composition containing the compound as an active ingredient, and more particularly, to a novel compound isolated from quamoclit, and to a composition for preventing or treating diabetes or diabetic complications containing the compound as an active ingredient. The novel compound derived from quamoclit according to the present invention has superior effects of reducing blood glucose levels, promoting insulin secretion, inhibiting VEGF expression, etc., and thus is effective in preventing or treating diabetes and various diabetic complications and further promotes treatment effects when administered in combination with conventional diabetes treatment agents.
